Old Web
English
Sign In
Acemap
>
authorDetail
>
Ariel A. Avilion
Ariel A. Avilion
Amgen
Multiple myeloma
Medicine
Cancer research
Immunology
Biomarker (medicine)
3
Papers
33
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Letter phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myeloma.
2020
Leukemia
Hans C. Lee
Noopur Raje
Ola Landgren
Vijay V. Upreti
Jin Wang
Ariel A. Avilion
Xuguang Hu
Erik Rasmussen
Gataree Ngarmchamnanrith
Hisaki Fujii
Andrew Spencer
Show All
Source
Cite
Save
Citations (25)
Open-Label, Phase 2 Study of Blinatumomab after First-Line Rituximab-Chemotherapy in Adults with Newly Diagnosed, High-Risk Diffuse Large B-Cell Lymphoma
2019
Blood
Deborah A. Katz
Michael P. Chu
Kevin A. David
Catherine Thieblemont
Nicholas J. Morley
Sharif S. Khan
Yuqi Chen
James Kalabus
Joan Morris
Abraham Anderson
Ariel A. Avilion
Eva González-Barca
Show All
Source
Cite
Save
Citations (8)
IDO Pathway Analysis for Identifying Novel Biomarkers in Multiple Myeloma
2018
Blood
Vladimir Petrovic
Jamie Wong
Cedric Dos Santos
Richard Smith
Dan Fitzpatrick
Robert D. Loberg
Ariel A. Avilion
Show All
Source
Cite
Save
Citations (0)
1